These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7921716

  • 1. Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.
    Başoğlu M, Marks IM, Kiliç C, Brewin CR, Swinson RP.
    Br J Psychiatry; 1994 May; 164(5):652-9. PubMed ID: 7921716
    [Abstract] [Full Text] [Related]

  • 2. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G.
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [Abstract] [Full Text] [Related]

  • 3. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
    Marks IM, Swinson RP, Başoğlu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S.
    Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC.
    J Psychiatr Res; 1993 Jun; 27 Suppl 1():155-70. PubMed ID: 8145176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.
    J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
    [Abstract] [Full Text] [Related]

  • 12. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ.
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [Abstract] [Full Text] [Related]

  • 17. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM, Krystal JH, Woods SW, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [Abstract] [Full Text] [Related]

  • 18. Panic control treatment for agoraphobia.
    Craske MG, DeCola JP, Sachs AD, Pontillo DC.
    J Anxiety Disord; 2003 Nov; 17(3):321-33. PubMed ID: 12727125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequence of improvement in agoraphobia with panic attacks.
    Rifkin A, Pecknold JC, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Dupont RL, Lesser I.
    J Psychiatr Res; 1990 Nov; 24(1):1-8. PubMed ID: 2195163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.